Dr Aleksandra Galetin is a Reader in Pharmacokinetics in Manchester Pharmacy School. In November 2004 she was appointed as a Pfizer Lecturer, following her position as a Postdoctoral Research Associate in the Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester. She is the recipient of the 2012 ISSX European New Investigator Award and 2015 AAPS Meritorious Manuscript Award for outstanding achievements in pharmaceutical sciences. She is currently serving on the ISSX Council and was a meeting chair of the 12th International ISSX Meeting held in Portland, Oregon, July 2019.
Dr Galetin is appointed on the expert panels such as International Transporter Consortium (ITC) and AAPS Drug Transport Focus Group Steering Committee. She co-edited a special issue in Clin Pharmacol Ther Nov 2018 dedicated to Advances in the role of drug transporters in drug development. Since 2013, Dr Galetin led/contributed to 9 ITC position papers, defining best practicesfor the application of endogenous biomarkers and PBPK modelling of transporter-mediated drug-drug interactions (DDI) among others topics.
In 2016, she had a sabbatical in FDA Office of Clinical Pharmacology where she provided expert advice on PBPK modelling and simulation of drug exposure in specific populations and prediction of DDIs in new drug applications.
Dr Galetin is a Deputy Director of CAPKR where research is carried out, supported by collaborations with different pharmaceutical companies and government funding. She has published more than 90 research papers in highly cited peer reviewed journals (H index 42, >4,700 citations), received numerous invitations to present at international meetings and supervised/mentored over 35 PhD students and postdoctoral research associates.